Anti-amnesic effects of withaferin A, a steroidal lactone isolated from Withania adpressa, on scopolamine-induced memory impairment in mice

Authors / Editors

Research Areas

No matching items found.

Publication Details

Output type: Journal article

UM6P affiliated Publication?: Yes

Author list: Ben Bakrim W., El Bouzidi L., Manouze H., Hafsa J., Sobeh M., Ba-M'hamed S., Bekkouche K., Kouisni L.

Publisher: Elsevier: Creative Commons Attribution Non-Commercial No-Derivatives License / Elsevier

Publication year: 2022

Journal: Arabian Journal of Chemistry (1878-5352)

Volume number: 15

Issue number: 1

ISSN: 1878-5352


Languages: English (EN-GB)

View in Web of Science | View on publisher site | View citing articles in Web of Science


Natural secondary metabolites have long served as sources of drugs against various health disorders, among them neurodegenerative diseases especially Alzheimer's disease (AD). Withanolides, isolated from Withania species, have shown acetylcholinesterase inhibition activity and their neuroprotective effects may be beneficial in the treatment of cholinergic system associated diseases, such as AD. This study was undertaken to highlight the neuroprotective effects of withaferin A (WA), isolated from W. adpressa leaves, using a scopolamine-induced memory impairment model in mice. The in vitro acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibition potentials of WA were assessed. The learning and memory enhancing activities of WA at different doses (1, 3 and 5 mg/kg) were investigated utilizing Novel Object Recognition (NOR) and Barnes maze (BM). WA substantially inhibited AChE and BuChE enzymes with IC50 values of 45.5 ± 0.14 and 68.2 ± 0.27 µg/mL, respectively. Noteworthy, rotarod results revealed no significant differences between WA and control groups. Also, learning, and spatial memory performance in NOR and BM tests were improved compared to the control groups. Furthermore, the activity of acetylcholinesterase in the brain was significantly inhibited (p < 0.05) by WA at the three tested doses. WA possessed certain affinity in both enzymes with low binding energy compared to the reference drug donepezil in a molecular docking study. This study displays that WA could be used for enhancing learning and memory impairment and appears to be a promising candidate for Alzheimer's disease treatment. © 2021 The Authors


No matching items found.


No matching items found.

Last updated on 2022-09-01 at 23:22